190 related articles for article (PubMed ID: 33341874)
21. The diagnostic application of RNA sequencing in patients with thyroid cancer: an analysis of 851 variants and 133 fusions in 524 genes.
Pagan M; Kloos RT; Lin CF; Travers KJ; Matsuzaki H; Tom EY; Kim SY; Wong MG; Stewart AC; Huang J; Walsh PS; Monroe RJ; Kennedy GC
BMC Bioinformatics; 2016 Jan; 17 Suppl 1(Suppl 1):6. PubMed ID: 26818556
[TBL] [Abstract][Full Text] [Related]
22. Machine-learning algorithms based on personalized pathways for a novel predictive model for the diagnosis of hepatocellular carcinoma.
Cheng B; Zhou P; Chen Y
BMC Bioinformatics; 2022 Jun; 23(1):248. PubMed ID: 35739471
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules.
He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y
BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630
[TBL] [Abstract][Full Text] [Related]
24. Development of prognostic signatures for intermediate-risk papillary thyroid cancer.
Brennan K; Holsinger C; Dosiou C; Sunwoo JB; Akatsu H; Haile R; Gevaert O
BMC Cancer; 2016 Sep; 16(1):736. PubMed ID: 27633254
[TBL] [Abstract][Full Text] [Related]
25. CCNA1 gene as a potential diagnostic marker in papillary thyroid cancer.
da Silva RM; Santos JN; Uno M; Chammas R; Kulcsar MAV; Sant'Anna LB; Canevari RA
Acta Histochem; 2020 Dec; 122(8):151635. PubMed ID: 33007517
[TBL] [Abstract][Full Text] [Related]
26. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma.
Qi W; Shi C; Zhang P; Feng L; Wang J; Chen D
Pathol Res Pract; 2020 Aug; 216(8):153037. PubMed ID: 32703500
[TBL] [Abstract][Full Text] [Related]
27. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
28. Identification of Prognostic Biomarkers in Papillary Thyroid Cancer and Developing Non-Invasive Diagnostic Models Through Integrated Bioinformatics Analysis.
Oskouie AA; Ahmadi MS; Taherkhani A
Microrna; 2022; 11(1):73-87. PubMed ID: 35068400
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of a three-immune-related gene signature prognostic risk model in papillary thyroid carcinoma.
Gan X; Guo M; Chen Z; Li Y; Shen F; Feng J; Cai W; Xu B
J Endocrinol Invest; 2021 Oct; 44(10):2153-2163. PubMed ID: 33620716
[TBL] [Abstract][Full Text] [Related]
30. Papillary thyroid carcinoma with a high tumor mutation burden has a poor prognosis.
Xie Z; Li X; Lun Y; He Y; Wu S; Wang S; Sun J; He Y; Xin S; Zhang J
Int Immunopharmacol; 2020 Dec; 89(Pt B):107090. PubMed ID: 33091816
[TBL] [Abstract][Full Text] [Related]
31. Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing.
Pan Q; Zhao J; Li M; Liu X; Xu Y; Li W; Wu S; Su Z
Carcinogenesis; 2020 Mar; 41(1):18-24. PubMed ID: 31560760
[TBL] [Abstract][Full Text] [Related]
32. Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations.
Abdullah MI; Junit SM; Ng KL; Jayapalan JJ; Karikalan B; Hashim OH
Int J Med Sci; 2019; 16(3):450-460. PubMed ID: 30911279
[TBL] [Abstract][Full Text] [Related]
33. PD-L1 and thyroid cytology: A possible diagnostic and prognostic marker.
Dell'Aquila M; Granitto A; Martini M; Capodimonti S; Cocomazzi A; Musarra T; Fiorentino V; Pontecorvi A; Lombardi CP; Fadda G; Pantanowitz L; Larocca LM; Rossi ED
Cancer Cytopathol; 2020 Mar; 128(3):177-189. PubMed ID: 31821747
[TBL] [Abstract][Full Text] [Related]
34. Ultrasound images-based deep learning radiomics nomogram for preoperative prediction of
Yu J; Zhang Y; Zheng J; Jia M; Lu X
Front Endocrinol (Lausanne); 2022; 13():1062571. PubMed ID: 36605945
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound and cytological characteristics of non-invasive follicular thyroid neoplasm with papillary-like nuclear features compared to papillary carcinomas.
Boursier L; Clerc Urmes I; Garon J; Klein M; Demarquet L
Ann Endocrinol (Paris); 2020 Feb; 81(1):28-33. PubMed ID: 32081363
[TBL] [Abstract][Full Text] [Related]
36. Development of a risk scoring system for patients with papillary thyroid cancer.
Pak K; Kim YH; Suh S; Goh TS; Jeong DC; Kim SJ; Kim IJ; Han ME; Oh SO
J Cell Mol Med; 2019 Apr; 23(4):3010-3015. PubMed ID: 30729678
[TBL] [Abstract][Full Text] [Related]
37. Utility of high b-value (2000 sec/mm2) DWI with RESOLVE in differentiating papillary thyroid carcinomas and papillary thyroid microcarcinomas from benign thyroid nodules.
Wang Q; Guo Y; Zhang J; Shi L; Ning H; Zhang X; Lu Y
PLoS One; 2018; 13(7):e0200270. PubMed ID: 30020961
[TBL] [Abstract][Full Text] [Related]
38. Prediction of Acquired Taxane Resistance Using a Personalized Pathway-Based Machine Learning Method.
Kim YR; Kim D; Kim SY
Cancer Res Treat; 2019 Apr; 51(2):672-684. PubMed ID: 30092623
[TBL] [Abstract][Full Text] [Related]
39. High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.
Barros-Filho MC; Marchi FA; Pinto CA; Rogatto SR; Kowalski LP
J Clin Endocrinol Metab; 2015 Jun; 100(6):E890-9. PubMed ID: 25867809
[TBL] [Abstract][Full Text] [Related]
40. Gene signature of the post-Chernobyl papillary thyroid cancer.
Handkiewicz-Junak D; Swierniak M; Rusinek D; Oczko-Wojciechowska M; Dom G; Maenhaut C; Unger K; Detours V; Bogdanova T; Thomas G; Likhtarov I; Jaksik R; Kowalska M; Chmielik E; Jarzab M; Swierniak A; Jarzab B
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1267-77. PubMed ID: 26810418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]